Tempus gets FDA clearance for AI pulmonary hypertension ECG detection
TEM Tempus received FDA clearance for its AI product intended to detect signs of pulmonary hypertension from standard ecgs.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
TEM Tempus received FDA clearance for its AI product intended to detect signs of pulmonary hypertension from standard ecgs.